Erythropoietin inhibits gamma-irradiation-induced apoptosis by upregulation of Bcl-2 and decreasing the activation of caspase 3 in human UT-7/erythropoietin cell line

Clinical and Experimental Pharmacology & Physiology
Yuan-Yuan LiuMing-Hui Yao

Abstract

1. Erythropoietin (EPO) can reverse radiotherapy-induced anaemia by stimulating bone marrow cells to produce erythrocytes. However, there are limited studies that address the mechanisms by which EPO exerts its beneficial effects in radiotherapy-induced anaemia. In the present study, we used a human bone marrow-derived EPO-dependent leukaemia cell line UT-7/EPO that progressed further in erythroid development to evaluate the anti-apoptotic effects of EPO on irradiated human erythroid progenitor. 2. The UT-7/EPO cells exposed to gamma-irradiation were cultured in the presence or absence of EPO at a concentration of 7 U/mL. The cell viability, cell apoptosis and the expression of apoptosis-related proteins Bcl-2, Bax and caspase 3 were examined. 3. The results showed that EPO protected the viability of human UT-7/EPO cells exposed to gamma-irradiation. EPO significantly inhibited gamma-irradiation-induced apoptosis in human UT-7/EPO cells: a significant decrease in the percentage of apoptotic cells was observed (62, 69 and 62% at 24, 48 and 72 h, respectively). Furthermore, EPO significantly increased the expression of Bcl-2 protein and the relative Bcl-2/Bax ratio, and decreased the activation of caspase 3 and formation of the p1...Continue Reading

References

May 14, 1999·Trends in Endocrinology and Metabolism : TEM·S N ConstantinescuH F Lodish
Aug 13, 1999·Genes & Development·A GrossS J Korsmeyer
Dec 28, 1999·Proceedings of the National Academy of Sciences of the United States of America·S OgilvyJ M Adams
Dec 18, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·G V Scagliotti, S Novello
Jun 14, 2002·Experimental Hematology·Nicholas Dainiak
May 11, 2004·Journal of Radiation Research·Vandana Nunia, P K Goyal
Nov 19, 2004·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Jürgen Dunst
Dec 14, 2004·The Oncologist·Kimberly BlackwellLinda Jolliffe
Mar 22, 2005·European Journal of Haematology·N Sae-UngK Muta
Jul 9, 2005·Biochemical and Biophysical Research Communications·Jin Hyup LeeJeen-Woo Park
Aug 23, 2005·International Journal of Radiation Oncology, Biology, Physics·John Varlotto, Mary Ann Stevenson
Dec 24, 2005·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Pilar M Samper OtsJosé M Delgado Pérez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.